Treatment with a tissue-selective oestrogen complex does not affect disease pathology but reduces pre-BI cells in lupus-prone mice

References

• Wahren-Herlenius M, Dörner T. Immunopathogenic mechanisms of systemic autoimmune disease. Lancet 2013;382:819–31.
   PubMed Web of Science ®Google Scholar
• Weckerle CE, Niewold TB. The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies. Clin Rev Allergy Immunol 2011;40:42–9.
   PubMed Web of Science ®Google Scholar
• Christou EAA, Banos A, Kosmara D, Bertsias GK, Boumpas DT. Sexual dimorphism in SLE: above and beyond sex hormones. Lupus 2019;28:3–10.
   PubMed Web of Science ®Google Scholar
• Singh RP, Hahn BH, Bischoff DS. Interferon genes are influenced by 17β-estradiol in SLE. Front Immunol 2021;12:725325.
   PubMed Web of Science ®Google Scholar
• Medina KL, Kincade PW. Pregnancy-related steroids are potential negative regulators of B lymphopoiesis. Proc Natl Acad Sci U S A 1994;91:5382–6.
   PubMed Web of Science ®Google Scholar
• Erlandsson MC, Jonsson CA, Lindberg MK, Ohlsson C, Carlsten H. Raloxifene- and estradiol-mediated effects on uterus, bone and B lymphocytes in mice. J Endocrinol 2002;175:319–27.
   PubMed Web of Science ®Google Scholar
• Young NA, Wu LC, Burd CJ, Friedman AK, Kaffenberger BH, Rajaram MV, et al. Estrogen modulation of endosome-associated toll-like receptor 8: an IFNα-independent mechanism of sex-bias in systemic lupus erythematosus. Clin Immunol 2014;151:66–77.
   PubMed Web of Science ®Google Scholar
• Sundstrom SA, Komm BS, Ponce-de-Leon H, Yi Z, Teuscher C, Lyttle CR. Estrogen regulation of tissue-specific expression of complement C3. J Biol Chem 1989;264:16941–7.
   PubMed Web of Science ®Google Scholar
• Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005;353:2550–8.
   PubMed Web of Science ®Google Scholar
• Sánchez-Guerrero J, Uribe AG, Jiménez-Santana L, Mestanza-Peralta M, Lara-Reyes P, Seuc AH, et al. A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med 2005;353:2539–49.
   PubMed Web of Science ®Google Scholar
• Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J, Hahn BH, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 2005;142:953–62.
   PubMed Web of Science ®Google Scholar
• Roubinian JR, Talal N, Greenspan JS, Goodman JR, Siiteri PK. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exp Med 1978;147:1568–83.
   PubMed Web of Science ®Google Scholar
• Talal N. Natural history of murine lupus. Modulation by sex hormones. Arthritis Rheum 1978;21:S58–63.
   PubMedGoogle Scholar
• Sen D, Keen RW. Osteoporosis in systemic lupus erythematosus: prevention and treatment. Lupus 2001;10:227–32.
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321–33.
   PubMed Web of Science ®Google Scholar
• Beral V, Bull D, Reeves G. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 2005;365:1543–51.
   PubMed Web of Science ®Google Scholar
• Silverman SL, Christiansen C, Genant HK, Vukicevic S, Zanchetta JR, de Villiers TJ, et al. Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial. J Bone Mineral Res 2008;23:1923–34.
   PubMed Web of Science ®Google Scholar
• Pickar JH, Lavenberg J, Pan K, Komm BS. Initial investigation into the optimal dose ratio of conjugated estrogens and bazedoxifene: a double-blind, randomized, placebo-controlled phase 2 dose-finding study. Menopause 2018;25:273–85.
   PubMed Web of Science ®Google Scholar
• Pickar JH, Boucher M, Morgenstern D. Tissue selective estrogen complex (TSEC): a review. Menopause 2018;25:1033–45.
   PubMed Web of Science ®Google Scholar
• Nordqvist J, Lagerquist MK, Grahnemo L, Koskela A, Islander U, Carlsten H. Osteoporosis in a murine model of postmenopausal lupus. Lupus 2020;29:58–66.
   PubMed Web of Science ®Google Scholar
• Nordqvist J, Engdahl C, Scheffler JM, Gupta P, Gustafsson KL, Lagerquist MK, et al. A tissue-selective estrogen complex as treatment of osteoporosis in experimental lupus. Lupus 2022;31:143–54.
   PubMed Web of Science ®Google Scholar
• Wardowska A, Komorniczak M, Skoniecka A, Bułło-Piontecka B, Lisowska KA, Dębska-Ślizień MA, et al. Alterations in peripheral blood B cells in systemic lupus erythematosus patients with renal insufficiency. Int Immunopharmacol 2020;83:106451.
   PubMed Web of Science ®Google Scholar
• Iwata S, Tanaka Y. B-cell subsets, signaling and their roles in secretion of autoantibodies. Lupus 2016;25:850–6.
   PubMed Web of Science ®Google Scholar
• Nordqvist J, Bernardi A, Islander U, Carlsten H. Effects of a tissue-selective estrogen complex on B lymphopoiesis and B cell function. Immunobiology 2017;222:918–23.
   PubMed Web of Science ®Google Scholar
• Bernardi AI, Andersson A, Grahnemo L, Nurkkala-Karlsson M, Ohlsson C, Carlsten H, et al. Effects of lasofoxifene and bazedoxifene on B cell development and function. Immun Inflamm Dis 2014;2:214–25.
   PubMedGoogle Scholar
• Youness A, Miquel CH, Guéry JC. Escape from X chromosome Inactivation and the female predominance in autoimmune diseases. Int J Mol Sci 2021;22:1114.
   PubMed Web of Science ®Google Scholar
• Eudy AM, Siega-Riz AM, Engel SM, Franceschini N, Howard AG, Clowse MEB, et al. Effect of pregnancy on disease flares in patients with systemic lupus erythematosus. Ann Rheum Dis 2018;77:855–60.
   PubMed Web of Science ®Google Scholar
• Scott JL, Wirth JR, Eudaly J, Ruiz P, Cunningham MA. Complete knockout of estrogen receptor alpha is not directly protective in murine lupus. Clin Immunol 2017;183:132–41.
   PubMed Web of Science ®Google Scholar
• Roubinian JR, Papoian R, Talal N. Androgenic hormones modulate autoantibody responses and improve survival in murine lupus. J Clin Invest 1977;59:1066–70.
   PubMed Web of Science ®Google Scholar
• Ceccarelli F, Orefice V, Perrone G, Pirone C, Perricone C, Truglia S, et al. Premature ovarian failure in patients affected by systemic lupus erythematosus: a cross-sectional study. Clin Exp Rheumatol 2020;38:450–4.
   PubMed Web of Science ®Google Scholar
• Smithson G, Medina K, Ponting I, Kincade PW. Estrogen suppresses stromal cell-dependent lymphopoiesis in culture. J Immunol 1995;155:3409–17.
   PubMed Web of Science ®Google Scholar
• Park JW, Moon SY, Lee JH, Park JK, Lee DS, Jung KC, et al. Bone marrow analysis of immune cells and apoptosis in patients with systemic lupus erythematosus. Lupus 2014;23:975–85.
   PubMed Web of Science ®Google Scholar
• Palanichamy A, Bauer JW, Yalavarthi S, Meednu N, Barnard J, Owen T, et al. Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus. J Immunol 2014;192:906–18.
   PubMed Web of Science ®Google Scholar
• Pearse G, Frith J, Randall KJ, Klinowska T. Urinary retention and cystitis associated with subcutaneous estradiol pellets in female nude mice. Toxicol Pathol 2009;37:227–34.
   PubMed Web of Science ®Google Scholar